Benefits Across Organ Systems
The study found GLP-1RA drugs, including and Wegovy, significantly benefit cognitive and behavioral health, reducing risks of seizures, substance addiction, suicidal ideation, self-harm, bulimia, and neurocognitive disorders like Alzheimer's and dementia.
Additionally, users experienced decreased risks of heart attacks, strokes, and conditions such as acute and chronic kidney disease, infections, and psychotic disorders, highlighting the drugs' wide-ranging positive effects.
Associated Risks and Cautions
Despite their benefits, GLP-1RA drugs were linked to increased risks of pancreatitis, kidney conditions, including kidney stones, and gastrointestinal issues like nausea, diarrhea, and in rare cases, stomach paralysis.
Experts urge caution due to the observational nature of the study, suggesting the findings should be interpreted cautiously as they do not match the definitive evidence from randomized trials.